Janney Montgomery Scott’s Alexion Pharmaceuticals ALXN Stock Holding History

Janney Montgomery Scott’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-38,451	Closed	-$6.01M	–	2424
2020 Q4	$6.01M	Sell	38,451 -6,655	-15%	-$855K	0.03%	483
2020 Q3	$5.16M	Buy	45,106 +1,277	+3%	+$138K	0.03%	475
2020 Q2	$4.92M	Sell	43,829 -392	-0.9%	-$41.6K	0.03%	460
2020 Q1	$3.97M	Buy	44,221 +10,637	+32%	+$1.04M	0.03%	457
2019 Q4	$3.63M	Sell	33,584 -545	-2%	-$58.3K	0.02%	572
2019 Q3	$3.34M	Buy	34,129 +11,408	+50%	+$1.29M	0.02%	569
2019 Q2	$2.98M	Buy	22,721 +2,627	+13%	+$339K	0.02%	584
2019 Q1	$2.72M	Buy	20,094 +1,339	+7%	+$166K	0.02%	594
2018 Q4	$1.83M	Buy	18,755 +1,707	+10%	+$202K	0.02%	673
2018 Q3	$2.37M	Sell	17,048 -173	-1%	-$21.7K	0.02%	645
2018 Q2	$2.14M	Sell	17,221 -265	-2%	-$31K	0.02%	658
2018 Q1	$1.95M	Buy	17,486 +4,069	+30%	+$486K	0.02%	661
2017 Q4	$1.6M	Buy	13,417 +34	+0.3%	+$4.14K	0.02%	738
2017 Q3	$1.88M	Sell	13,383 -158	-1%	-$21.5K	0.02%	641
2017 Q2	$1.65M	Buy	13,541 +5,186	+62%	+$604K	0.02%	647
2017 Q1	$1.01M	Buy	8,355 +671	+9%	+$86.5K	0.01%	832
2016 Q4	$940K	Sell	7,684 -834	-10%	-$102K	0.01%	796
2016 Q3	$1.04M	Buy	+8,518	New	+$1.1M	0.02%	642
2016 Q2	–	Sell	-6,790	Closed	-$945K	–	1242
2016 Q1	$945K	Sell	6,790 -537	-7%	-$78.8K	0.02%	536
2015 Q4	$1.4M	Sell	7,327 -242	-3%	-$42.3K	0.04%	443
2015 Q3	$1.18M	Buy	7,569 +1,211	+19%	+$221K	0.03%	475
2015 Q2	$1.15M	Buy	6,358 +1,322	+26%	+$228K	0.02%	713
2015 Q1	$873K	Buy	5,036 +618	+14%	+$112K	0.02%	972
2014 Q4	$817K	Buy	4,418 +333	+8%	+$61.7K	0.02%	970
2014 Q3	$677K	Buy	4,085 +250	+7%	+$41.1K	0.01%	1067
2014 Q2	$599K	Sell	3,835 -1,482	-28%	-$234K	0.01%	1110
2014 Q1	$809K	Buy	5,317 +513	+11%	+$81.6K	0.02%	844
2013 Q4	$638K	Sell	4,804 -312	-6%	-$37.4K	0.02%	933
2013 Q3	$594K	Buy	+5,116	New	+$561K	0.02%	900